| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $3.2M | — | +8.4% |
| SG&A Expense | $3.1M | — | +6.0% |
| Pre-tax Income | -$6.9M | — | -42.9% |
| Income Tax | $7K | — | — |
| Net Income | -$6.9M | — | -43.3% |
| EPS (Basic) | -$0.58 | — | -18.4% |
| EPS (Diluted) | -$0.58 | — | -18.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $24.5M | +702.6% | +474.8% |
| Current Assets | $26.5M | +335.4% | +360.1% |
| Total Assets | $27.3M | +292.7% | +305.6% |
| Current Liabilities | $6.3M | +77.9% | +169.6% |
| Total Liabilities | $9.7M | +38.4% | +87.0% |
| Stockholders' Equity | $17.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.6M | — | -5.7% |
| Capital Expenditures | $25K | — | — |
| Investing Cash Flow | -$25K | — | — |
| Financing Cash Flow | $26.1M | — | +429.9% |
| Free Cash Flow | -$4.6M | — | -6.3% |
| +936.3% |